Squarepoint’s GT Biopharma GTBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
– Sell
-14
Closed -$33K – 3124
2021
Q4
$33K Buy
+14
New +$52.4K ﹤0.01% 3064
2021
Q2
– Sell
-22
Closed -$113K – 3416
2021
Q1
$113K Buy
+22
New +$96.1K ﹤0.01% 2870

Other funds holding GTBP

Squarepoint's GTBP Position: Q1 2022 in Review

Squarepoint sold out of GT Biopharma (GTBP) in Q1 2022, closing a stake of 14 shares — an estimated $33K sold.

Squarepoint first reported a position in GTBP in Q1 2021 and held it in 2 quarters. The position peaked at $113K in Q1 2021. 53 funds tracked by Wall St. Rank hold GTBP as of Q1 2022.

  • Squarepoint reported no remaining GT Biopharma position as of Q1 2022 after selling out during the quarter.
  • Squarepoint sold 14 GT Biopharma shares in Q1 2022, an estimated $33K.
  • Squarepoint first reported a position in GT Biopharma in Q1 2021 and held it in 2 quarters.
  • Squarepoint's GT Biopharma position peaked at $113K in Q1 2021.
  • 53 funds tracked by Wall St. Rank held GT Biopharma as of Q1 2022.

Based on Squarepoint's 13F filing for Q1 2022, filed 16 May 2022.